Megan was recently recognized in the 2024 edition of the “Best Lawyers: Ones to Watch” in Health Care Law. She truly enjoys getting to integrate her science degree from Clemson into her everyday practice.
Megan is a life sciences attorney who represents a variety of business types, including drug and device manufacturers, clinical laboratories, research sponsors, clinical research sites, and contract research organizations, among others. Megan also coordinates due diligence efforts on behalf of private equity firms to perform risk-based regulatory and compliance assessments of investments in these types of companies. Because she has dedicated a substantial portion of her practice to the laboratory industry, Megan is a co-lead of her firm’s Clinical Laboratories Focused Initiative. She regularly advises lab clients and stakeholders on state and federal compliance considerations; in particular, Megan is experienced in guiding clients through the development of direct access testing business models, including aspects such as corporate structure, risk management, and regulatory compliance.
